Hancock Whitney’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Hancock Whitney's AMED Position: Q3 2025 in Review
Hancock Whitney sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,056 shares — an estimated $596K sold.
Hancock Whitney first reported a position in AMED in Q3 2017 and held it in 17 quarters. The position peaked at $15.3M in Q3 2018. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Hancock Whitney reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Hancock Whitney sold 6,056 Amedisys shares in Q3 2025, an estimated $596K.
- Hancock Whitney first reported a position in Amedisys in Q3 2017 and held it in 17 quarters.
- Hancock Whitney's Amedisys position peaked at $15.3M in Q3 2018.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Hancock Whitney's 13F filing for Q3 2025, filed 17 Nov 2025.